(no title)
mquirion | 5 years ago
The common cold doesn't kill. There's almost no economic impetus for a cure. Note, I said "almost." There may be some, but there's still not enough to drive R&D in a corporate lab, and certainly not enough to drive policy in a government lab.
There are 100 other questions that would follow from science to logistic once you answer: Can we create a drug that kills infection in clinical tests?
epmaybe|5 years ago
throwmeaway_pls|5 years ago
mquirion|5 years ago
Plus NyQuil and AS can be produced and sold in such a way as to net a profit. We don't know that's the case for a cold cure.
karlshea|5 years ago
lm28469|5 years ago
Enginerrrd|5 years ago
Compare that to a specific drug targeting a small percentage of the causative agents of the common cold, for which the duration is short enough that by the time you'd get a reliable test back, you'd have gotten over your cold anyway.
There's just not much of a practical use for such a drug.
fiftyfifty|5 years ago
jokethrowaway|5 years ago
I agree the government wastes money on a lot of things (13bln per day!) and that's exactly why I'd rather have the market come up with what we should be spending our money on.
newsbinator|5 years ago